2 research outputs found

    Single‐cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers

    No full text
    An immunosuppressive state is regulated by various factors in the tumor microenvironment (TME), including, but not limited to, metabolic plasticity of immunosuppressive cells and cytokines secreted by these cells. We used single‐cell RNA‐sequencing (scRNA‐seq) data and applied single‐cell flux estimation analysis to characterize the link between metabolism and cellular function within the hypoxic TME of colorectal (CRC) and lung cancer. In terms of metabolic heterogeneity, we found myeloid cells potentially inclined to accumulate glutamine but tumor cells inclined to accumulate glutamate. In particular, we uncovered a tumor‐associated macrophage (TAM) subpopulation, APOE+CTSZ+TAM, that was present in high proportions in tumor samples and exhibited immunosuppressive characteristics through upregulating the expression of anti‐inflammatory genes. The proportion of APOE+CTSZ+TAM and regulatory T cells (Treg) were positively correlated across CRC scRNA‐seq samples. APOE+CTSZ+TAM potentially interacted with Treg via CXCL16–CCR6 signals, as seen by ligand–receptor interactions analysis. Notably, glutamate‐to‐glutamine metabolic flux score and glutamine synthetase (GLUL) expression were uniquely higher in APOE+CTSZ+TAM, compared with other cell types within the TME. GLUL expression in macrophages was positively correlated with anti‐inflammatory score and was higher in high‐grade and invasive tumor samples. Moreover, spatial transcriptome and multiplex immunofluorescence staining of samples showed that APOE+CTSZ+TAM and Treg potentially colocalized in the tissue sections from CRC clinical samples. These results highlight the specific role and metabolic characteristic of the APOE+CTSZ+TAM subpopulation and provide a new perspective for macrophage subcluster‐targeted therapeutic interventions or metabolic checkpoint‐based cancer therapies

    Measurement of branching fractions of Λc+pKS0KS0\Lambda_c^+\to{}pK_S^0K_S^0 and Λc+pKS0η\Lambda_c^+\to{}pK_S^0\eta at Belle

    No full text
    We present a study of a singly Cabibbo-suppressed decay Λc+pKS0KS0\Lambda_c^+\to{}pK_S^0K_S^0 and a Cabibbo-favored decay Λc+pKS0η\Lambda_c^+\to{}pK_S^0\eta based on 980 fb1\rm fb^{-1} of data collected by the Belle detector, operating at the KEKB energy-asymmetric e+ee^+e^- collider. We measure their branching fractions relative to Λc+pKS0\Lambda_c^+\to{}pK_S^0: B(Λc+pKS0KS0)/B(Λc+pKS0)=(1.48±0.08±0.04)×102\mathcal{B}(\Lambda_c^+\to{}pK_S^0K_S^0)/\mathcal{B}(\Lambda_c^+\to{}pK_S^0)={(1.48 \pm 0.08 \pm 0.04)\times 10^{-2}} and B(Λc+pKS0η)/B(Λc+pKS0)=(2.73±0.06±0.13)×101\mathcal{B}(\Lambda_c^+\to{}pK_S^0\eta)/\mathcal{B}(\Lambda_c^+\to{}pK_S^0)={(2.73\pm 0.06\pm 0.13)\times 10^{-1}}. Combining with the world average B(Λc+pKS0)\mathcal{B}(\Lambda_c^+\to{}pK_S^0), we have the absolute branching fractions: B(Λc+pKS0KS0)=(2.35±0.12±0.07±0.12)×104\mathcal{B}(\Lambda_c^+\to{}pK_S^0K_S^0) = {(2.35\pm 0.12\pm 0.07 \pm 0.12 )\times 10^{-4}} and B(Λc+pKS0η)=(4.35±0.10±0.20±0.22)×103\mathcal{B}(\Lambda_c^+\to{}pK_S^0\eta) = {(4.35\pm 0.10\pm 0.20 \pm 0.22 )\times 10^{-3}}. The first and second uncertainties are statistical and systematic, respectively, while the third ones arise from the uncertainty on B(Λc+pKS0)\mathcal{B}(\Lambda_c^+\to{}pK_S^0). The mode Λc+pKS0KS0\Lambda_c^+\to{}pK_S^0K_S^0 is observed for the first time and has a statistical significance of > ⁣10σ>\!10\sigma. The branching fraction of Λc+pKS0η\Lambda_c^+\to{}pK_S^0\eta has been measured with a threefold improvement in precision over previous results and is found to be consistent with the world average
    corecore